Return On Equity in % of Nuo Therapeutics, Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nuo Therapeutics, Inc. quarterly and annual Return On Equity history and change rate from Q1 2012 to Q3 2025.
  • Nuo Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 1,030%.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2024 was -398%, a 12.1% decline from 2023.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2023 was -355%, a 164% decline from 2022.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2022 was -135%, a 186% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Nuo Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 1,030% +1,377% 01 Jul 2025 30 Sep 2025
Q2 2025 -2,697% -2,298% -575% 01 Apr 2025 30 Jun 2025
Q1 2025 -528% -57% -12% 01 Jan 2025 31 Mar 2025
Q4 2024 -398% -43% -12% 01 Oct 2024 31 Dec 2024
Q3 2024 -347% -52% -18% 01 Jul 2024 30 Sep 2024
Q2 2024 -399% -198% -98% 01 Apr 2024 30 Jun 2024
Q1 2024 -471% -328% -230% 01 Jan 2024 31 Mar 2024
Q4 2023 -355% -220% -164% 01 Oct 2023 31 Dec 2023
Q3 2023 -294% -181% -159% 01 Jul 2023 30 Sep 2023
Q2 2023 -201% -88% -78% 01 Apr 2023 30 Jun 2023
Q1 2023 -143% +86% +38% 01 Jan 2023 31 Mar 2023
Q4 2022 -135% -290% -186% 01 Oct 2022 31 Dec 2022
Q3 2022 -114% -180% -272% 01 Jul 2022 30 Sep 2022
Q2 2022 -113% -154% -377% 01 Apr 2022 30 Jun 2022
Q1 2022 -229% -265% -732% 01 Jan 2022 31 Mar 2022
Q4 2021 156% +146% +1,424% 01 Oct 2021 31 Dec 2021
Q3 2021 66% +85% 01 Jul 2021 30 Sep 2021
Q2 2021 41% +52% 01 Apr 2021 30 Jun 2021
Q1 2021 36% +8% +27% 01 Jan 2021 31 Mar 2021
Q4 2020 10% -98% -91% 01 Oct 2020 31 Dec 2020
Q3 2020 -19% -127% -117% 01 Jul 2020 30 Sep 2020
Q2 2020 -11% -236% -105% 01 Apr 2020 30 Jun 2020
Q1 2020 29% -348% -92% 01 Jan 2020 31 Mar 2020
Q4 2019 109% -441% -80% 01 Oct 2019 31 Dec 2019
Q3 2019 108% -7,013% -98% 01 Jul 2019 30 Sep 2019
Q2 2019 225% +725% 01 Apr 2019 30 Jun 2019
Q1 2019 376% +732% 01 Jan 2019 31 Mar 2019
Q4 2018 550% +775% 01 Oct 2018 31 Dec 2018
Q3 2018 7,121% 01 Jul 2018 30 Sep 2018
Q2 2018 -501% 01 Apr 2018 30 Jun 2018
Q1 2018 -356% 01 Jan 2018 31 Mar 2018
Q4 2017 -225% 01 Oct 2017 31 Dec 2017
Q3 2016 435% +487% 01 Jul 2016 30 Sep 2016
Q2 2016 448% +440% +5,625% 05 May 2016 30 Jun 2016
Q1 2016 465% +522% 01 Jan 2016 31 Mar 2016
Q4 2015 -2,604% -2,494% -2,258% 01 Oct 2015 31 Dec 2015
Q3 2015 -51% +83% +62% 01 Jul 2015 30 Sep 2015
Q2 2015 8% +118% 01 Apr 2015 30 Jun 2015
Q1 2015 -58% +12% +18% 01 Jan 2015 31 Mar 2015
Q4 2014 -110% -49% -80% 01 Oct 2014 31 Dec 2014
Q3 2014 -134% -81% -151% 01 Jul 2014 30 Sep 2014
Q2 2014 -110% -63% -134% 01 Apr 2014 30 Jun 2014
Q1 2014 -70% -20% -38% 01 Jan 2014 31 Mar 2014
Q4 2013 -62% -1% -2% 01 Oct 2013 31 Dec 2013
Q3 2013 -54% +9% +14% 01 Jul 2013 30 Sep 2013
Q2 2013 -47% +48% +50% 01 Apr 2013 30 Jun 2013
Q1 2013 -51% +113% +69% 01 Jan 2013 31 Mar 2013
Q4 2012 -60% 01 Oct 2012 31 Dec 2012
Q3 2012 -62% 01 Jul 2012 30 Sep 2012
Q2 2012 -95% 01 Apr 2012 30 Jun 2012
Q1 2012 -164% 01 Jan 2012 31 Mar 2012

Nuo Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -398% -43% -12% 01 Jan 2024 31 Dec 2024
2023 -355% -220% -164% 01 Jan 2023 31 Dec 2023
2022 -135% -290% -186% 01 Jan 2022 31 Dec 2022
2021 156% +146% +1,424% 01 Jan 2021 31 Dec 2021
2020 10% -98% -91% 01 Jan 2020 31 Dec 2020
2019 109% -441% -80% 01 Jan 2019 31 Dec 2019
2018 550% +775% 01 Jan 2018 31 Dec 2018
2017 -225% 01 Jan 2017 31 Dec 2017
2015 -2,604% -2,494% -2,258% 01 Jan 2015 31 Dec 2015
2014 -110% -49% -80% 01 Jan 2014 31 Dec 2014
2013 -62% -1% -2% 01 Jan 2013 31 Dec 2013
2012 -60% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.